The Interferon-Lambda Family Celebrates 20 Years of Scientific Discovery.

COVID-19 IFNL4 genotype interferon lambda monoclonal antibody receptor

Journal

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
ISSN: 1557-7465
Titre abrégé: J Interferon Cytokine Res
Pays: United States
ID NLM: 9507088

Informations de publication

Date de publication:
09 2023
Historique:
pmc-release: 01 09 2024
medline: 21 9 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

It has now been 20 years since the original discovery of the interferon λ (IFN-λ) family (Kotenko et al., 2003; Sheppard et al., 2003) and 10 years since the subsequent discovery of IFN-λ4 (Prokunina-Olsson et al., 2013). The IFN-λ family (type III IFNs) includes 4 members: IFN-λ1, 2, 3, and 4, and all 4 of these proteins signal through the same heterodimeric receptor complex: IFN-λR1 plus IL-10R2. Throughout the past 20 years, much has been learned about the IFN-λ family and the important role of these cytokines in antiviral responses against viruses such as hepatitis C virus, influenza A virus, and SARS-CoV-2. This special issue of the

Identifiants

pubmed: 37725009
doi: 10.1089/jir.2023.0122
pmc: PMC10623059
doi:

Substances chimiques

Interferon Lambda 0
Interferons 9008-11-1
Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-362

Références

J Interferon Cytokine Res. 2023 Sep;43(9):403-413
pubmed: 37499093
J Interferon Cytokine Res. 2023 Sep;43(9):427-434
pubmed: 37725010
Immunity. 2017 Mar 21;46(3):379-392
pubmed: 28329704
Sci Immunol. 2021 May 14;6(59):
pubmed: 33990378
J Interferon Cytokine Res. 2023 Sep;43(9):394-402
pubmed: 37366802
J Interferon Cytokine Res. 2014 Nov;34(11):829-38
pubmed: 24786669
J Interferon Cytokine Res. 2023 Sep;43(9):414-426
pubmed: 37725008
Eur J Immunol. 2016 Nov;46(11):2639-2649
pubmed: 27615517
J Interferon Cytokine Res. 2023 Sep;43(9):379-393
pubmed: 37253131
J Interferon Cytokine Res. 2023 Sep;43(9):370-378
pubmed: 36880961
N Engl J Med. 2023 Feb 9;388(6):518-528
pubmed: 36780676
EMBO J. 2013 Nov 27;32(23):3055-65
pubmed: 24169568
Nat Immunol. 2003 Jan;4(1):63-8
pubmed: 12469119
Nat Immunol. 2003 Jan;4(1):69-77
pubmed: 12483210
Sci Immunol. 2021 Aug 19;6(62):
pubmed: 34413139
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
J Interferon Cytokine Res. 2019 Oct;39(10):586-591
pubmed: 30998425
J Interferon Cytokine Res. 2023 Sep;43(9):363-369
pubmed: 37289801
Lancet Respir Med. 2021 May;9(5):498-510
pubmed: 33556319
J Interferon Cytokine Res. 2023 Sep;43(9):435-438
pubmed: 37347978
Nat Genet. 2013 Feb;45(2):164-71
pubmed: 23291588

Auteurs

Raymond P Donnelly (RP)

Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

Ludmila Prokunina-Olsson (L)

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH